Beyond the arrhythmia, AF often signals broader pathological processes that impair cardiac function and reduce quality of life and life expectancy.5 Many of these conditions are closely linked to social determinants of health, disproportionately affecting populations with socioeconomic disadvantage. Effective AF management requires addressing both the arrhythmia and its underlying contributors.4 
C – Comorbidity and risk factor management
Warfarin
Natalie Cooper[/caption]
Professor Michael Kidd[/caption]
Restoring faith in sun safety
Investigations reveal many popular sunscreens don’t live up to their labels. But pharmacists can promote holistic sun protection.
Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
Making antidepressant tapering safer and easier
In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.
How pharmacists can stop the slide in immunisation coverage
As vaccine-preventable diseases resurface, pharmacies must lead informed conversations that close gaps and restore community protection.
Meet the new Aboriginal and Torres Strait Islander CSI lead
The new Aboriginal and Torres Strait Islander Pharmacy Practice CSI lead will guide reform through culturally safe practice.
Restoring faith in sun safety
Investigations reveal many popular sunscreens don’t live up to their labels. But pharmacists can promote holistic sun protection.
Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
Making antidepressant tapering safer and easier
In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.
How pharmacists can stop the slide in immunisation coverage
As vaccine-preventable diseases resurface, pharmacies must lead informed conversations that close gaps and restore community protection.
Meet the new Aboriginal and Torres Strait Islander CSI lead
The new Aboriginal and Torres Strait Islander Pharmacy Practice CSI lead will guide reform through culturally safe practice.
POPULAR
A cup of tea, a Bex and a good lie down
Immortalised in Australian slang, the analgesic phenacetin (used in Bex powder) is wrapped up in the development of the modern pharmaceutical industry and has...
Pfizer COVID-19 vaccine health hubs announced
The Federal Government is calling on community pharmacists to help vaccinate millions of Australians against COVID-19.
Landmark Australian study on oxycodone prescribing
Oxycodone is the most prescribed strong opioid in Australia. Yet little was known about its use and prescribing patterns – until now.
Triptans downscheduled to S3 medicines
Last year, the Therapeutic Goods Administration announced that certain triptans will be available over the counter in 2021.
New CAL D instruction for antibiotics
A new cautionary advisory label for antibiotics that will replace decades of advice to take the medicines ‘until all used’ or ‘until all taken’ will be released next year.
Pharmacists help patients as Ozempic shortage gets even worse
Late last week, the TGA announced there would be no semaglutide stock from mid-November 2022 until the end of March next year.
